Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share

Journal of Managed Care Pharmacy

Volumn 12, Issue 8, 2006, Pages 665-676

  Cecil, William T ^a   Barnes, John ^b   Shea, Terence ^c   Coulter, Steven L ^c  

^a Health Policy Research   (United States)

^b BlueCross BlueShield of Tennessee   (United States)

^c BlueCross BlueShield of Tennessee   (United States)

Author keywords

Benefit tier; Coinsurance; Copayment; Cross price elasticity; Expenditure; Own price elasticity; Physician office visit

Indexed keywords

ADAPALENE; AMFEPRAMONE; ANABOLIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIOBESITY AGENT; BENZPHETAMINE; FLUCONAZOLE; HUMAN GROWTH HORMONE; PALIVIZUMAB; PHENDIMETRAZINE; PHENTERMINE; RETINOIC ACID; SIBUTRAMINE; TETRAHYDROLIPSTATIN; THALIDOMIDE;

ADULT; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MALE; MEDICAL RECORD; PRESCRIPTION; REIMBURSEMENT; TRAVEL; ADOLESCENT; COST; DRUG COST; ECONOMICS; HEALTH CARE DELIVERY; HEALTH MAINTENANCE ORGANIZATION; INSURANCE; MIDDLE AGED; TIME; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; COST SHARING; DRUG COSTS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE CLAIM REPORTING; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; OFFICE VISITS; TENNESSEE; TIME FACTORS; TRAVEL;

EID: 33847324907     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2006.12.8.665     Document Type: Article

References (41)

1. Centers for Medicare and Medicaid Services. National health expenditure tables. Available at: http://www.cms.hhs.gov/statistics/nhe/historical/. Accessed August 25, 2006.
2. Reissman D. Health plans lose ground to PBM carve-outs. Drug Benefit Trends. 2004;16(1):15-18.
3. Lee K. Rx carve-outs escalate as cost control. BenefitNews.com, June 15, 2002. Available at: http://www.Benefitnews.com. Accessed August, 28, 2006.
4. Mercer Human Resource Consulting. Prescription Drug Benefit Plans: A Buyer's Guide. Oakland, CA: California HealthCare Foundation; January 2003.
5. Pindyck RS, Rubinfeld DL. Microeconomics. 6th ed. Upper Saddle River, NJ: Pearson Prentice Hall; 2005:32, 34-35.
6. Folland S, Goodman AC, Stano M. The Economics of Health and Health Care. Upper Saddle River, NJ: Pearson Education, Inc.; 2004:169, 345-46.
7. Phelps CE, Newhouse JP. Effects of coinsurance: a multivariate analysis. Soc Secur Bull. 1972;35(6):20-28.
8. Newhouse J. Free for all? Lessons from the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press; 1996.
9. O'Brien B. The effect of patient charges on the utilization of prescription medicines. J Health Econ. 1989;8(1):109-32.
10. Manning WG, Newhouse JP, Duan N. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987;77(3):252-77.
11. BlueCross BlueShield of Tennessee, 2002. Three-tier formulary. AdvancePCS; 2002.
12. BlueCross BlueShield of Tennessee, 2003.Three-tier formulary. AdvancePCS; 2003.
13. Chiang AC, Wainwright K. Mathematical Economics. New York, NY: McGraw-Hill/Irwin; 2005:182.
14. Gujarati DN. Basic Econometrics. New York, NY: McGraw-Hill/Irwin; 2003:175-176, 370, 638, 650.
15. Deaton A, Muellbauer J. Economics and Consumer Behavior. Cambridge, UK: Cambridge University Press;1980:17.
16. Friedman M. How to cure health care. Hoover Dig. No. 3, 2001.
17. Melek S. The Costs of Mental Health Parity. Schaumburg, IL: Society of Actuaries; 2005.
18. Cubanski J, Schauffler HH. Mandated health insurance benefits: tradeoffs among benefits, coverage and costs? [issue brief]. California Health Policy Roundtable; July 2002.
19. Maryland Health Care Commission. Annual mandated health insurance services report. January 19, 2006. Available at: http://mhcc.maryland.gov/ health_insurance/_healthinsurance.htm. Accessed May 6, 2006.
20. Kopenski F. Your pharmacy trends may be higher than you think: a case study [client notes]. Milliman USA; 2002.
21. Dulleck U, Kerschbamer R. On doctors, mechanics, and computer specialists: the economics of credence goods. J Econ Lit. 2006;44(1):5-42.
22. Fisher ES, Wennberg D, Stukel T, et al. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138:273-87.
23. Jones AM. Health econometrics. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Vol. 1A. Amsterdam, North-Holland: Elsevier Science B.V.; 2000:308.
24. Wooldridge J. Introductory Econometrics: A Modern Approach. Belmont, CA: South-Western College Publishing; 2000:420.
25. Schwartz M, Ash AS. Evaluating risk-adjustment models empirically. In: Iezzoni LI, ed. Risk Adjustment: Measuring Health Care Outcomes. Chicago, IL: Health Administration Press; 2003:233.
26. Mas-Colell A, Whinston M, Green J, et al. Microeconomic Theory. New York, NY: Oxford University Press; 1995:26.
27. Acton JP. Nonmonetary factors in the demand for medical services: some empirical evidence. J Polit Econ. 1975;83(3):595-614.
28. Coffey RM. The effect of time price on the demand for medical-care services. J Hum Res. 1983;18(3):407-24.
29. Akerlof G. The market for "LEMONS": quality uncertainty and the market mechanism. Q J Econ. 1970;84(3):488-500.
30. Rosett RN, Huang, L. The effect of health insurance on the demand for medical care. J Polit Econ. 1973;81:281-305.
31. Fuchs VR, Kramer MJ. Determinants of Expenditures for Physicians' Services in the United States, 1948-1968 [occasional paper No. 117]. New York, NY: National Bureau of Economic Research; 1972.
32. Wedig GJ. Health status and the demand for health. Results on price elasticities. J Health Econ. 1988;7:151-63.
33. Contoyannis P, Hurley J, Grootendorst P, et al. Estimating price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada. Health Econ. 2005;14(9):909-23.
34. Coulson NE, Stuart BC. Insurance choice and the demand for prescription drugs. South Econ J. 1995;85(2):122-26.
35. Harris BL, Stergachis A, Reid A. The effect of pharmaceutical copayments on utilization and cost of pharmaceuticals in a health maintenance organization. Med Care. 1990;28:907-17.
36. Hughes D, McGuire A. Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure. Health Econ. 1995;4(3):213-20.
37. Johnson RE, Goodman MJ, Hornbrook MC, et al. The effect of increased prescription drug cost sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care. 1997;35:1119-31.
38. Smith DG. The effects of copayments and generic substitution on the use and costs of prescription drugs. Inquiry. 1993;30:189-98.
39. Meissner BL, Moore M, Shinogle JA, et al. Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids. J Manag Care Pharm. 2004;10(3):226-33.
40. Baker L, Wagner T, Singer S, et al. Use of the Internet and e-mail for health care information. JAMA. 2003;289:2400-06.
41. Bundorf M, Wagner T, Singer S, et al. Who searches the Internet for health information? Health Serv Res. 2006;41:819-36.